Skip to content

Panacea Life Sciences Holdings, Inc.

PLSH

CIK 0001552189

← back to feed
Revenue (TTM)
$2.48M
+46.6% YoY Q1 May 2024
Net Income (TTM)
−$7.25M
+12.3% YoY Q1 May 2024
EPS Diluted (TTM)
−$0.45
+22.6% YoY Q1 May 2024
Gross Margin
50.0%
Q1 May 2024
Operating Margin
-194.9%
Q1 May 2024
Net Margin
-292.3%
Q1 May 2024
Free Cash Flow (TTM)
−$1.25M
Q1 May 2024
Cash
$107.64K
Q1 May 2024
Total Debt
$827.3K
Q1 May 2024
Shares Outstanding
17.65M sh
Q1 May 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings